Pregnancy: No clinical data are available from women who became pregnant while taking Solifenacin. The potential risk for humans is unknown. Caution should be exercised when prescribing to pregnant women.
Breastfeeding: No data on the excretion of Solifenacin in human milk are available. The use of Solifenacin should therefore be avoided during breastfeeding.